Issue (1)
2015
Issue
10, (5) (2015)
Vaccine Biotechnology (Special issue). Biotechnology Journal Editorial (5)
2022
Editorial
13, 923393 (2022)
Editorial: Immunoglobulin Glycosylation Analysis: State-of-the-Art Methods and Applications in Immunology. Frontiers in Immunology 2021
Editorial
Preface to Advances in Glycobiotechnology. Advances in Glycobiotechnology, pp. i - vi (2021)
2018
Editorial
36 (22), pp. 3061 - 3063 (2018)
Vaccine Technology VI: Innovative and integrated approaches in vaccine development. Vaccine 2015
Editorial
10 (5), pp. 657 - 658 (2015)
Can modern vaccine technology pursue the success of traditional vaccine manufacturing? Biotechnology Journal
Editorial
33 (35), pp. 4219 - 4220 (2015)
Vaccine Technology V: The art of taking vaccines to disease prevention (Preface). Vaccine Technology V: The art of taking vaccines to disease prevention Patent (4)
2020
Patent
Protective Interfering Nucleic Acid Molecule And Virus - Like Particle, Virsl Vector, or Virus Particle Containing the same as well as Pharmaceutical Composition Containing the Protective Interfering Nucleic Acid and its use. US 2020/0392504A1 (2020)
Patent
Enzymatic method for preparation of GDP-fucose. EP 3719135A1 (2020)
2019
Patent
Plug Flow Tubular Bioreactor , System Containing the same and Method for Production of Virus. US 20190119616A1 (2019)
Patent
Method for the Separation of Virus Compositions Including Depletion and Purification thereof. US 20190085300A1 (2019)
Preprint (6)
2024
Preprint
Detection, isolation and characterisation of phage-host complexes using BONCAT and click chemistry. (2024)
Preprint
Macrophage- and CD4+ T cell-derived SIV differ in glycosylation, infectivity and neutralization sensitivity. (2024)
2021
Preprint
Community Evaluation of Glycoproteomics Informatics Solutions Reveals High-Performance Search Strategies of Serum N- and O-Glycopeptide Data. (2021)
Preprint
Semi-continuous propagation of influenza A virus and its defective interfering particles: analyzing the dynamic competition to select candidates for antiviral therapy. (2021)
Preprint
Interferon induction and not replication interference mainly determines anti-influenza virus activity of defective interfering particles. (2021)
Preprint
Critical Assessment of Metaproteome Investigation (CAMPI): A Multi-Lab Comparison of Established Workflows. (2021)